25 Jan 2022 Biotalys achieves breakthrough in protein expression increasing commercial potential for its first biofungicide Evoca Member news
24 Jan 2022 BIMZELX[®] (bimekizumab) approved in Japan for the treatment of plaque psoriasis, generalized pustular psoriasis and psoriatic erythroderma Member news
21 Jan 2022 argenx announces VYVGART™ approval in Japan for the treatment of generalized myasthenia gravis Member news
19 Jan 2022 Jyseleca®▼ (Filgotinib) licensed for the treatment of adult patients with moderately to severely active ulcerative colitis in Great Britain Member news
14 Jan 2022 Mithra announces positive top-line results from Donesta® Phase 3 studies in menopausal women Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
